Hepatitis E virus: the current scenario.

Area of Science:

• Virology
• Hepatology
• Public Health

Background:

• Hepatitis E virus (HEV) is a significant cause of acute hepatitis globally, especially in developing nations.
• HEV has four genotypes (1-4), with genotypes 1 and 2 primarily infecting humans and causing large outbreaks via contaminated water.
• Genotypes 3 and 4 are zoonotic, transmitted from animals like pigs, and can cause chronic infections in immunocompromised individuals.

Purpose of the Study:

• To provide a comprehensive review of the current understanding of Hepatitis E virus infection.
• To discuss the molecular biology, pathobiology, and epidemiology of HEV.
• To explore therapeutic interventions and strategies for HEV control, including vaccine development.

Main Methods:

• Literature review of recent advancements in HEV research.
• Analysis of epidemiological data on HEV outbreaks and transmission routes.
• Evaluation of current therapeutic approaches and vaccine efficacy studies.

Main Results:

• HEV infection presents with high attack rates in young adults and severe outcomes in pregnant women (20-30% mortality).
• Zoonotic transmission of HEV from animals to humans is a significant concern.
• A subunit vaccine demonstrates efficacy but is not yet commercially available.

Conclusions:

• HEV infection remains a major public health challenge, necessitating improved sanitation and water safety.
• Understanding HEV's molecular biology and epidemiology is crucial for effective control.
• Further research into vaccine development and therapeutic strategies is essential for combating HEV.